Skip to main navigation
Great Science. Great Medicine
About
Overview
Management Team
Board of Directors
Partnering
Contact Us
Pipeline
Overview
Orphan and Rare Diseases
Chronic Kidney Disease
Immuno-Oncology and Other Therapeutic Areas
Preclinical Candidates
Other Inflammatory and Autoimmune Diseases
Vercirnon
CCX507
Th17 Driven Diseases and CCR6
Diseases
Orphan and Rare Diseases
Chronic Kidney Disease
Immuno-oncology
Other Inflammatory and Autoimmune Diseases
Science
Investors
Overview
News Releases
Events & Presentations
Financials & Filings
SEC Filings
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Management Team
Board of Directors
Committee Composition
Investor FAQs
Contact Us
Careers
Culture
Benefits
Job Postings
About
Overview
Management Team
Board of Directors
Partnering
Contact Us
Pipeline
Overview
Orphan and Rare Diseases
Chronic Kidney Disease
Immuno-Oncology and Other Therapeutic Areas
Preclinical Candidates
Other Inflammatory and Autoimmune Diseases
Vercirnon
CCX507
Th17 Driven Diseases and CCR6
Diseases
Orphan and Rare Diseases
Chronic Kidney Disease
Immuno-oncology
Other Inflammatory and Autoimmune Diseases
Science
Investors
Overview
News Releases
Events & Presentations
Financials & Filings
SEC Filings
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Management Team
Board of Directors
Committee Composition
Investor FAQs
Contact Us
Careers
Culture
Benefits
Job Postings
Company
Overview
Management Team
Board of Directors
Advisory Board
Strategic Partners
In the Community
Contact
Pipeline
Diseases
Chronic Kidney Disease
Orphan and Rare Diseases
Other Inflammatory and Autoimmune Diseases
Immuno-oncology
Science
Overview
Complement System and Rare Diseases
Chemokines and Inflammation/Autoimmune Disorders
Chemokines and Immuno-oncology
Investors
Overview
News Releases
Events & Presentations
SEC Filings
Stock Information
Historic Stock Lookup
Analyst Coverage
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
Investor FAQs
Contact Us
Careers
Culture
Job Postings
Benefits
Go to...
Company
Overview
Management Team
Board of Directors
Advisory Board
Strategic Partners
In the Community
Contact
Pipeline
Diseases
Chronic Kidney Disease
Orphan and Rare Diseases
Other Inflammatory and Autoimmune Diseases
Immuno-oncology
Science
Overview
Complement System and Rare Diseases
Chemokines and Inflammation/Autoimmune Disorders
Chemokines and Immuno-oncology
Investors
Overview
News Releases
Events & Presentations
SEC Filings
Stock Information
Historic Stock Lookup
Analyst Coverage
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
Investor FAQs
Contact Us
Careers
Culture
Job Postings
Benefits
Investors
ChemoCentryx, Inc. Fourth Quarter 2020 Financial Results Conference Call
03/01/21 5:00 PM EST
Click here for Webcast
Supporting Materials
View Presentation
16.9 MB
Investor Relations
Overview
News Releases
Events & Presentations
Financials & Filings
SEC Filings
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Management Team
Board of Directors
Committee Composition
Investor FAQs
Contact Us
Shareholder Tools
Printed Materials
Email Alerts Subscription
Snapshot
Print
Share
Facebook
LinkedIn
Twitter
RSS